Publication: Clinical and immunological effects of azithromycin in Behcet's disease
dc.contributor.author | MUMCU, GONCA | |
dc.contributor.authors | Mumcu, G; Ergun, T; Elbir, Y; Eksioglu-Demiralp, E; Yavuz, S; Atalay, T; Direskeneli, H | |
dc.date.accessioned | 2022-03-12T17:18:44Z | |
dc.date.available | 2022-03-12T17:18:44Z | |
dc.date.issued | 2005 | |
dc.description.abstract | BACKGROUND: The aim of this study was to evaluate the effects of azithromycin on mucocutaneous manifestations, oral health and immune response in Behcet's disease (BD). METHODS: Eight BD patients with active mucocutaneous symptoms were treated with azithromycin for 4 weeks. Oral health, clinical manifestations and in vitro interleukin (IL)-12, interferon (IFN)-gamma, IL-10 and monocyte chemotactic protein (MCP)-1 responses were evaluated before and after treatment. RESULTS: The number of folliculitic lesions, healing time of oral ulcers and scores of plaque indexes (PLIs) were lower after azithromycin treatment (P < 0.05). Scores of PLIs correlated positively with the healing time of oral ulcers (P = 0.02). Although a trend towards increased stimulated IL-10 responses with azithromycin was observed, no statistically significant difference was found. Stimulated and unstimulated MCP-1, IFN-gamma and IL-12 responses were similar before and after treatment (P > 0.05). CONCLUSION: Azithromycin was observed to be effective in decreasing folliculitic lesions and fastening the healing time of oral ulcers in BD. | |
dc.identifier.doi | 10.1111/j.1600-0714.2004.00265.x | |
dc.identifier.eissn | 1600-0714 | |
dc.identifier.issn | 0904-2512 | |
dc.identifier.pubmed | 15610401 | |
dc.identifier.uri | https://hdl.handle.net/11424/228003 | |
dc.identifier.wos | WOS:000225792200003 | |
dc.language.iso | eng | |
dc.publisher | WILEY | |
dc.relation.ispartof | JOURNAL OF ORAL PATHOLOGY & MEDICINE | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | antimicrobial treatment | |
dc.subject | azithromycin | |
dc.subject | Behcet's disease | |
dc.subject | cytokines and chemokines | |
dc.subject | PERIODONTAL TISSUE DISPOSITION | |
dc.subject | SYMPTOMS | |
dc.subject | PNEUMONIAE | |
dc.subject | COLCHICINE | |
dc.subject | MACROLIDES | |
dc.subject | INFECTION | |
dc.subject | INDUCTION | |
dc.subject | ANTIGENS | |
dc.title | Clinical and immunological effects of azithromycin in Behcet's disease | |
dc.type | article | |
dspace.entity.type | Publication | |
local.avesis.id | 461b7285-2f61-4ad2-bf35-d9012cd6342c | |
local.import.package | SS17 | |
local.indexed.at | WOS | |
local.indexed.at | SCOPUS | |
local.indexed.at | PUBMED | |
local.journal.numberofpages | 4 | |
oaire.citation.endPage | 16 | |
oaire.citation.issue | 1 | |
oaire.citation.startPage | 13 | |
oaire.citation.title | JOURNAL OF ORAL PATHOLOGY & MEDICINE | |
oaire.citation.volume | 34 | |
relation.isAuthorOfPublication | 15fb5c8c-4e72-485b-bf3d-c6e191e3f5aa | |
relation.isAuthorOfPublication.latestForDiscovery | 15fb5c8c-4e72-485b-bf3d-c6e191e3f5aa |